Articles related to PREVENTIVE MEDICINE

In a prospective cohort of more than 112,000 French adults, higher intake of several commonly used food preservatives was associated with increased risks of hypertension and cardiovascular disease, though the observational design cannot determine whether the additives themselves caused the observed outcomes.

The FDA approved updated 2026-2027 formulations of Pfizer-BioNTech, Moderna, and Novavax COVID-19 vaccines targeting the XFG variant, aligning with advisory committee recommendations for the upcoming vaccination season.

Analysis of NHANES data suggests that adoption of the 2026 ACC/AHA dyslipidemia guidelines could make approximately 25 million additional US adults eligible to consider statin therapy, primarily through incorporation of PREVENT risk equations and expanded emphasis on long-term cardiovascular risk.

Higher circulating xylitol levels were associated with increased rates of major adverse cardiovascular events in two large population cohorts, although the observational findings do not establish that xylitol directly causes cardiovascular harm.

Targeted vitamin D supplementation successfully addressed widespread vitamin D insufficiency among post-myocardial infarction patients but did not significantly reduce major adverse cardiovascular events during more than four years of follow-up.

Adding coronary artery calcium scoring to PREVENT-ASCVD risk equations produced only modest improvements in 10-year ASCVD risk prediction among adults aged 45 to 79 years, with the greatest potential value observed in patients with borderline or intermediate estimated risk.